Showing 2621-2630 of 5693 results for "".
- Santen and NTC Announce Positive Outcome of European Decentralised Procedure (DCP) for Ducressa Post-Cataract Surgery Antibiotic/Steroid Combinationhttps://modernod.com/news/santen-and-ntc-announce-positive-outcome-of-for-ducressa-post-cataract-surgery-antibiotic-steroid-combination/2477944/Santen EMEA and NTC, have announced the completion and positive outcome of the European Decentralised Procedure (DCP) for a fixed dose combination of levofloxacin and dexamethasone (Ducressa), offering reduced exposure to antibiotics following cataract surgery.1 Levofloxacin is a broa
- Registration Now Open for Neuro-Optometric Rehabilitation Association Online Conferencehttps://modernod.com/news/registration-now-open-for-neuro-optometric-rehabilitation-association-online-conference/2477928/Registration is now open for the Neuro-Optometric Rehabilitation Association, International (NORA) online conference at www.nora2020.com. The conference will be available live online on Saturday, September 12–Sunday, September 13. All presentations will be av
- Versant Health Debuts New Eye Care Resource Centerhttps://modernod.com/news/versant-health-debuts-new-eye-care-resource-center/2477925/In celebration of Healthy Vision Month this July, Versant Health has launched a new resource center providing tools that enable people to take command of their vision health. Designated by the National Eye Institute, Healthy Vision Month is dedicated to highlighting the importance of eye h
- ImprimisRx’s Patented Klarity-C 0.1% Cyclosporine Preservative-Free Formulation May Now Be Prescribed By Florida’s 2,000 Optometristshttps://modernod.com/news/imprimisrxs-patented-klarity-c-0-1-cyclosporine-preservative-free-formulation-may-now-be-prescribed-by-floridas-2000-optometrists/2477907/ImprimisRx announced its Klarity-C preservative-free formulation (0.1% cyclosporine emulsion) may now be prescribed by Florida’s nearly 2,000 optometrists as a result of the Florida Board of Optometry’s recent additions to its Formulary of Topical Ocular Pharmaceutical Agents. Klarity-C w
- Study: Dexamethasone Reduces Death In Hospitalized Patients With Severe Respiratory Complications of COVID-19https://modernod.com/news/scientists-hail-dexamethasone-as-major-breakthrough-in-treating-covid-19/2477901/Results of a large trial show that the inexpensive and widely used steroid dexamethasone has the potential to save lives in patients with severe cases of COVID-19. In what some scientists are calling a “major breakthrough” in the coronavirus pandemic, dexamethasone, which is used to reduce
- Aldeyra Therapeutics Receives Orphan Medicinal Product Designation from the European Commission for ADX-2191 Retinal Disease Programhttps://modernod.com/news/aldeyra-therapeutics-receives-orphan-medicinal-product-designation-from-the-european-commission-for-adx-2191-retinal-disease-program/2477898/Aldeyra Therapeutics announced that ADX-2191 has been designated an orphan medicinal product by the European Commission for the treatment of retinal detachment. ADX-2191 is an investigational therapy in clinical development in the U.S. for the prevention of proliferative vitreoretinopathy (PVR),
- Tarsus Pharmaceuticals Announces Positive Results of Phase 2a Study for TP-03 to Treat Demodex Blepharitishttps://modernod.com/news/tarsus-pharmaceuticals-announces-positive-results-of-phase-2a-study-for-tp-03-to-treat-demodex-blepharitis/2477893/Tarsus Pharmaceuticals announced positive results of its phase 2a Mars Study and the release later this month of the results of a phase 2b randomized controlled study. The Mars study demonstrated that the use of TP-03 for 4 weeks was well-tolerated and showed promising efficacy in the treatment o
- Modernizing Medicine Introduces Modmed SynapSYS Development Platformhttps://modernod.com/news/modernizing-medicine-introduces-modmed-synapsys-development-platform/2479520/Modernizing Medicine has introduced modmed synapSYS, a new app development platform and suite of application programming interfaces (APIs). Modmed synapSYS was designed to allow third-party providers, healthcare institutions, and the developer community to easily interface Modernizing Medicine te
- Five Coronavirus Treatments In Developmenthttps://modernod.com/news/five-coronavirus-treatments-in-development/2479524/Right now, there is only one drug shown by rigorous scientific testing to be helpful for treating COVID-19. That drug is the antiviral medication called remdesivir, made by Gilead Sciences. But remdesivir’s proven benefits
- Strategic National Stockpile Aims to Get 400M Syringes by December for COVID-19 Vaccine: Officialshttps://modernod.com/news/strategic-national-stockpile-aims-to-get-400m-syringes-by-december-for-covid-19-vaccine-officials/2477888/Trump administration officials want to stockpile 400 million syringes and needles by December in anticipation of a COVID-19 vaccine, according to a FierceHealthcare report. Administration officials testified before Congress on Tuesday on the procurement of supplies during the COVID-19 pand